Navigation Links
New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019

Fairfax, VA (PRWEB) December 06, 2013

In their latest Special Report, “The Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019,” PharmSource experts provide a quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products.

Founded on the industry’s most comprehensive database of the dose CMO industry - PharmSource’s Strategic Advantage Database of Contract Service Providers - the analytical model and assumptions are fully explained so readers can understand how the analysis and conclusions were established. PharmSource is considered to be the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Projections are presented for key processing capabilities, including aseptic fill, lyophilized vials and prefilled devices such as syringes, cartridges and proprietary devices. The study analyzes the current capacity and planned additions to capacity of contract manufacturers, as well as the plans by major sponsors to increase in-house capacity.

This 80-page report gives important, expert insight that is not available in any other source. Over 25 tables and more than 20 charts and graphs throughout the report illustrate major points and trends. This report should be required reading for:

  •     CMO executives: this report is an indispensable resource for understanding the industry and a critical input for strategic planning efforts.
  •     Sourcing and procurement executives: this report is a critical resource for understanding crucial components of the supply base that will provide insights for supplier selection and management.
  •     Private equity investors: this report gives a deeper understanding of the market and important insight for identifying potential investment targets.

To learn more about PharmSource's special reports, click here.

About PharmSource
PharmSource Information Services, Inc. is a respected provider of business intelligence on contract drug development and manufacture. PharmSource assists Biotechnology and Pharmaceutical companies in implementing and managing sourcing strategies and programs. They also provide business development products and services to companies that serve the biotechnology and pharmaceutical industries. Since 1996, organizations involved in contract Pharma services have continuously relied on PharmSource publications, databases, surveys and consulting services to provide timely, accurate information and analysis. Visit PharmSource on the web at or contact them at +1-703-383-4903 (USA, eastern time-zone).

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioInformatics LLC Multi-Sponsor Market Report – In-depth Exploration of the U.S. Market for Biosimilar Drugs
2. In-Depth Black Mold Removal Guide Released by My Cleaning Products, Company Offers Complimentary Sample of Molderizer and Safe Shield Along With It
3. The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics
4. An In-Depth Understanding of the Chinese Pharmaceutical Industry
5. In-depth Research on China Organic Silicon Industry, 2013-2017 (Update Version)
6. In-Depth Research and Development Forecast of China Fluorine Chemical Industry, 2013-2017
7. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
Post Your Comments:
(Date:6/27/2016)... SAN DIEGO , June 27, 2016  Sequenom, ... company committed to enabling healthier lives through the development ... Supreme Court of the United States ... Federal courts that the claims of Sequenom,s U.S. Patent ... the patent eligibility criteria established by the Supreme Court,s ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):